Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PetVivo HoldingsPETV 27 10-Year Share Buyback Ratio is -32.80 as of Jun. 2026. GuruFocus rates PETV with a GF Score™ of 27/100 and a GF Value™ of $0.47 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 445 Medical Devices & Instruments companies, PetVivo Holdings ranks worse than 91.69% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. PetVivo Holdings's current 10-Year Share Buyback Ratio was -32.80%.
PETV's 10-Year Share Buyback Ratio is ranked worse than 91.69% of 445
companies
in the Medical Devices & Instruments industry
Industry Median: -3.3
vs PETV: -32.80
PetVivo Holdings (OTCPK:PETV) 10-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
PetVivo Holdings 10-Year Share Buyback Ratio Related Terms
PETV vs RDGL, MODD, GTHP: 10-Year Share Buyback Ratio Comparison
For the Medical Devices subindustry, PetVivo Holdings's 10-Year Share Buyback Ratio, along with its competitors' market caps and 10-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PetVivo Holdings 10-Year Share Buyback Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PetVivo Holdings's 10-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where PetVivo Holdings's 10-Year Share Buyback Ratio falls into.
PetVivo Holdings 10-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from ten years ago to the current year. The annualized percentage change is calculated with least-square regression based on the eleven years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 10-Year Share Buyback Ratio of -32.80 mean?
PetVivo Holdings (PETV) has a 10-Year Share Buyback Ratio of -32.80 as of Jun. 2026. The 10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. View historical data for PetVivo Holdings and its competitors. According to the industry distribution chart, PetVivo Holdings ranks #408 out of 445 companies in the Medical Devices & Instruments industry, placing it in the top 91.7%.
Is PetVivo Holdings' 10-Year Share Buyback Ratio too high?
PetVivo Holdings' current 10-Year Share Buyback Ratio is -32.80. Based on the distribution chart, PetVivo Holdings ranks #408 out of 445 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, PetVivo Holdings has a GF Score™ of 27/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PetVivo Holdings' 10-Year Share Buyback Ratio compare to RDGL and MODD?
According to the Medical Devices & Instruments industry distribution chart, PetVivo Holdings ranks #408 out of 445 companies for 10-Year Share Buyback Ratio. This places PetVivo Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year Share Buyback Ratio for a Medical Devices & Instruments company?
A good 10-Year Share Buyback Ratio depends on the Medical Devices & Instruments industry context. However, 10-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year Share Buyback Ratio mean?
A high 10-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. View historical data for PetVivo Holdings and its competitors. PetVivo Holdings's current 10-Year Share Buyback Ratio is -32.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PetVivo Holdings stock overvalued right now?
Based on GuruFocus' analysis, PetVivo Holdings (PETV) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.47, compared to a current price of $0.68 — trading 44.7% above its estimated fair value. The current 10-Year Share Buyback Ratio is -32.80. PetVivo Holdings' overall GF Score™ is 27/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year Share Buyback Ratio calculated?
10-Year Share Buyback Ratio is calculated from a company's financial statements. For PetVivo Holdings (PETV), the current 10-Year Share Buyback Ratio is -32.80 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PetVivo Holdings (PETV) Overvalued in 2026?
Based on GuruFocus' analysis, PetVivo Holdings stock appears to be overvalued.
The current stock price of $0.68 is trading 44.7% above its estimated GF Value™ of $0.47.
GuruFocus considers PetVivo Holdings to be Significantly Overvalued.
Key valuation signals for PETV:
10-Year Share Buyback Ratio: -32.80
GF Value™: $0.47 vs. price of $0.68 (44.7% above fair value)
No single metric tells the full story. See the PETV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PetVivo Holdings Inc is an emerging biomedical device company. It is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for companion animals. The product pipeline includes approximately seventeen products intended to treat animals and people. Its patent protection extends to biomaterials, products, production processes, and methods of use provided by the company's portfolio of several patents. The company has also begun the commercialization of its product Spryng with OsteoCushion technology, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions such as osteoarthritis in dogs and horses.
27GF Score
Get the complete analysis for PETV
10-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PETV has been successfully added to your 
